A novel automated microchip flow-chamber system to quantitatively evaluate thrombus formation and antithrombotic agents under blood flow conditions
The first paper on T-TAS system’s concept verification study.
T-TAS instrument and AR chip’s assay principle are explained.
A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process
T-TAS instrument and PL chip’s assay principle are explained.
It was suggested that T-TAS can distinguish the pharmacological effects of various antiplatelet drugs under physiological shear rates.
Total Thrombus-Formation Analysis System(T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
The paper describes the role of T-TAS in cardiovascular disease.
The author concludes that T-TAS is a useful index for evaluating the total antithrombotic effects of combination antithrombotic agents in patients with various cardiovascular diseases.
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia
The first paper on the T-TAS 01 HD assay.
The thrombogenic potential of thrombocytopenic patients before and after platelet transfusion was assessed with T-TAS HD assay.
HD assay results reflected the hemostatic function of patients with thrombocytopenita.
Contribute to the worldwide development of medical treatment and the realization of a healthy society by developing and providing CHIGAI (differentiation) technologies, products and services.
Create and expand our medical business as a new business pillar for Fujimori’s Next100.
Generate and expand our business in the targeted field by creating the “Only One” values (i.e., technology, products and services).